Dear Editor,
Voltage-gated potassium channels (KV) play vital roles in electrically excitable and non-excitable cells. They usually open with membrane depolarization and allow the flow of K+ ions. Ion flow through these channels is curtailed by time-dependent entry into non-conducting inactivated states1. Inactivation allows channels to close even in the face of continued stimulation and can occur rapidly (in ms, N-type) or slowly (in s, C-type). This tight governance of ion flow by inactivation is essential for the timing and control functions of KV channels.
KV1.3 was the first ion channel discovered in immune cells three decades ago2 and exhibited only C-type inactivation3. During antigen presentation, the channel clusters at the immunological synapse and promotes Ca2+ signaling. Effector memory T cells up-regulate KV1.3 during activation4. Many toxins from scorpions, sea anemones, and parasitic worms block KV1.3 by binding to an external vestibule at the outer entrance to the channel’s pore. Protein engineering of these peptide toxins has resulted in selective KV1.3 inhibitors that preferentially suppress proliferation, cytokine secretion, and in vivo migration of effector memory T cells5. One inhibitor, dalazatide, advanced to human trials where it ameliorated symptoms in patients with plaque psoriasis6. These physiological and therapeutic importance of KV1.3 motivated us to elucidate its molecular structure.
To produce a stable homogeneous sample for structural study, we removed residues 1–52 of human KV1.3; these residues are absent in mouse and rat KV1.3. The channel’s voltage-dependence of activation, use-dependent inactivation, and sensitivity to the KV1.3-specific inhibitor ShK-EWSS at low picomolar concentrations (Fig. 1a) matched that of KV1.3 in T cells7. Since the auxiliary subunit KVβ2 was reported to promote expression of hKV1.38, we expressed hKV1.3 with KVβ2.1, purified the complex, and finally obtained an overall 3.2 Å resolution map (Supplementary Fig. S1). The hKV1.3–KVβ2.1 complex assembled as a tetramer with a four-fold symmetry (Fig. 1b). Each subunit of KV1.3 contained a transmembrane domain (TMD) and a cytoplasmic T1 domain, which was a docking platform for the auxiliary β subunit9. The TMD consisted of a voltage sensor domain (VSD, helices S0–S4), which responded to changes in membrane potential, and a pore-forming domain (helices S5–S6). The KV1.3 T1 domain, helices S5–S6, and KVβ2.1 were at higher resolution (~2.5–3.5 Å), which allowed for accurate model building. The local resolution for the VSD was between 4 and 5 Å. As a result, most side chains were invisible in these regions. We built the VSD model based on its strong main chain density and the corresponding region in crystal structure of KV1.2-2.1 chimera (PDB ID 2R9R)10. The final model includes KVβ2.1 with a NADP+ molecule (Supplementary Fig. S2a), which is a cofactor for KVβ2 subunit9, the T1 domain, and the TMD. Human KV1.3–KVβ2.1 complex exhibits overall dimensions of ~140 Å × 100 Å × 100 Å, and the length and width of the TMD are ~55 and ~80 Å, respectively (Fig. 1b). Unsurprisingly, the overall architecture of hKV1.3–KVβ2.1 is remarkably similar to that of rat KV1.2-2.1 chimera-KVβ210 (Supplementary Fig. S2b). By aligning the TMDs of KV1.3 and the chimera, we observed a small shift of the KV1.3 T1 domain and KVβ2.1 (Supplementary Fig. S2c), which was also mentioned in the cryo-EM structure of the chimera in nanodiscs comparing to its crystal structure11.
In the VSD, the side-chain density for most charged amino acids are not discerned in the map, as was reported for the KV1.2 crystal structure12. The S4 helix contains six positively charged residues (R364, R367, R370, R373, K376, and R379) that are numbered R1, R2, R3, R4, K5, and R6 in Fig. 1c, d. F306 located near the midpoint of the membrane separates negatively charged residues located at the outer (E254 on S1 and E299 on S2) and inner (E225 on S0, E309 on S2, and E332 on S3) ends of the VSD (Fig. 1d). F306, E309, and D332 form a charge transfer center in the VSD, which facilitates movement of positively charged residues in the S4 in response to changes in membrane voltage13. The α-carbon of R4 is at the level of F306, and R1, R2 and R3 are close to the extracellular surface of the channel, consistent with the VSD being in a depolarized conformation. The angle of the S4–S5 linker (Supplementary Fig. S2c) is similar to that of the KV1.2-2.1 chimera in open conformation10.
In the pore-domain, the selectivity filter and pore helices of KV1.3 superimpose well onto that of the KV1.2 (Supplementary Fig. S2d). These two structures differ in the loops linking the S5 and S6 helices. These loops form the walls of the external vestibule where toxins bind. These differences in vestibule may contribute to the differing sensitivities of KV1.3 and KV1.2 to pore-blocking toxins. EM densities corresponding to putative K+ ions were observed at ion-binding sites 1, 3, and 4 but not site 2 (Fig. 1e). The cryo-EM map of the KV1.2-2.1 chimera embedded in nanodiscs also lacked the K+ density at site 2, and one possibility of this absence was suggested to represent a C-type inactivated state11. Moreover, side-chain density for Y447 in the filter is weak compared to nearby residues V445 and W436 (Fig. 1f and Supplementary Fig. S2e), and the density corresponding to the side chain of D449 is absent in our map (Fig. 1f). It is possible that the missing side-chain density of D449 is caused by radiation damage. However, it is also possible that an indication of flexibility, which means that Y447 and D449 can adopt various rotameric conformations, suggesting that critical hydrogen bonds related to C-type inactivation between Y447–T441 and D449–W43614 may be weakened or broken. These observations suggest that the KV1.3 structure may be related to a C-type inactivated conformation.
Earlier studies showed that the mouse KV1.3 H404N mutant exhibited very rapid C-type inactivation15. We generated the corresponding human KV1.3 H451N mutant and tested its electrophysiological properties. The H451N mutant exhibited 60-fold faster inactivation (τh = 7 ms) than KV1.3 (τh = 440 ms) (Fig. 1g). We determined the cryo-EM structure of the H451N-mutant hKV1.3–KVβ2.1 complex and obtained an overall resolution of 3.3 Å (Supplementary Figs. S3,S4 and Table S1). The overall structures of hKV1.3–KVβ2.1 and hKV1.3 H451N–KVβ2.1 superimpose very well. The main differences between these two structures are in the selectivity filter. The external part of the mutant’s filter is dilated (Fig. 1h, i). In hKV1.3’s structure, the carbonyl oxygen atoms of G446, Y447, and G448 in diagonally opposed subunits are 4.8, 5.0, and 8.6 Å apart, which widen to 6.7, 8.0, and 11.6 Å in the mutant, respectively. Under the selectivity filter in both hKV1.3 and the mutant, the inner helix bundle forms an open gate, which is sufficiently wide to allow passage of a fully hydrated K+ ion.
Close inspection reveals that dilation is not caused only by outward motion of residues in the mutant’s selectivity filter. Moreover, the carbonyl groups of G446 and Y447 rotate and cause their carbonyl oxygen atoms to deviate from the central axis of the pore (Fig. 1j and Supplementary Fig. S5). In KV channels, the precise location of carbonyl oxygen atoms in the filter is essential for selective conduction of K+ ions. The deviated carbonyl oxygen atoms contribute to the breakdown of K+ coordination at sites 1 and 2. There is no density at site 2, while the density at site 1 is stronger than that at sites 3 and 4 (Fig. 1h). In the dilation model of C-type inactivation, a hydrated Na+ has been proposed to replace the K+ at site 1 in the C-type inactivated state1. The density may be Na+, but since K+ was the only cation we used during protein purification, the identity of the density at site 1 remains to be clarified.
The stability of the outer pore has been proposed, based on mutagenesis studies of the Shaker channel, to be maintained by a network of hydrogen bonds composed of intra-subunit (W434–D447) and inter-subunit (Y445–T439) interactions14. These weaken as the channel opens and rupture as the channel collapses into a non-conducting C-type inactivated state. The corresponding residues in hKV1.3 are W436, T441, Y447, and D449. We performed molecular dynamics (MD) simulations to identify the H/N451 site’s effect on the network in hKV1.3 and in the mutant. A dominant intra-subunit W436–D449 interaction was observed in hKV1.3, together with a secondary H451–D449 inter-subunit interaction. In the mutant, inter-subunit N451–D449 and W436–N451 interactions dominated, with occasional formation of intra-subunit W436–D449 pairs. The hydrogen bonding strengths of the N451–D449 and H451–D449 pairs are comparable according to our density-functional theory calculations, but steric hindrance encountered in the presence of the imidazole ring of H451 limits its rotation compared to the more flexible N451, resulting in the N451–D449 hydrogen bond being favored over H451–D449 (Supplementary Figs. S6 and S7).
Based on the cryo-EM structures and the MD simulation results, we propose that H451N-mutant hKV1.3 inactivates rapidly because the pore-stabilizing hydrogen bond network is weakened, leading to external pore dilation. In hKV1.3, H451 makes “illicit” interactions with D449 and W436 in neighboring subunits, and these interfere with the hydrogen bond network, rendering the channel more prone to enter the C-type inactivated state. In the rapidly inactivating mutant, N451 makes inter-subunit interactions with D449 and W436 more frequently because it is more flexible than wild-type H451. Consequently, Y447, which located in position close to both D449 and W436 in the same subunit, is possibly destabilized, moves outwards, and rotates away from the pore axis, leading to dilation of the external pore. This deformation limits the ability of carbonyl oxygen atoms of G446 and Y447 to coordinate K+ ions at sites 1 and 2.
In summary, we report the cryo-EM structures of human lymphocyte KV1.3 channel and a rapidly inactivating mutant H451N. In these two structures, the VSD is in a depolarized conformation and the inner gate is open. Due to the incomplete ion occupancy in the selectivity filter and the weak side-chain density for Y447 and D449, both the wild-type and the H451N-mutant KV1.3 structures may be related to C-type inactivated conformation. These two structures provide the basis for guiding the design of new KV1.3 inhibitors, which could stabilize the inactivated conformation, for use as immunomodulators.
Supplementary information
Acknowledgements
We thank the Center for Integrative Imaging of University of Science and Technology of China (Hefei), and the Center of Cryo-Electron Microscopy of Zhejiang University (Hangzhou) for providing the cryo-EM facility support. We thank Profs. Michael Cahalan, George Augustine, Heike Wulff, Gyorgy Panyi, James Hall, Youxing Jiang, and Shashi Bhushan for critical reading and for their valuable suggestions. This work was funded by the National Natural Science Foundation of China (21825703, 32000854, 31670776, U1832181), the National Key R&D Project of China (2016YFA0400903, 2017YFA0505301), and the Singapore Ministry of Education under its Singapore Ministry of Education Academic Research Fund Tier 2 (MOE2016-T2-2-032).
Author contributions
S.L., K.G.C., and C.T. conceived the project. Y. Zhao performed cloning, expression and purification. S.L. prepared cryo-EM grids, collected and processed data, built models and analyzed the structures. H.D. and Y.Y. performed MD simulation studies. L.X. and Y. Zhang performed the patch-clamp experiments. S.T.O. provided technical advice for the patch-clamp experiments. S.L. and K.G.C. wrote the manuscript. L.Z. and C.T. supervised the project.
Data availability
Cryo-EM density maps and atomic coordinates of hKV1.3–KVβ2.1 and hKV1.3 H451N–KVβ2.1 have been deposited in the Electron Microscopy Data Bank under accession number EMD-31148 and 31149, and in the Protein Data Bank under accession code 7EJ1 and 7EJ2, respectively.
Conflict of interest
The authors declare no competing interests.
Footnotes
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
These authors contributed equally: Sanling Liu, Yue Zhao, Hao Dong
Contributor Information
Hao Dong, Email: donghao@nju.edu.cn.
Longhua Zhang, Email: zlhustc@ustc.edu.cn.
Changlin Tian, Email: cltian@ustc.edu.cn.
Supplementary information
The online version contains supplementary material available at 10.1038/s41421-021-00269-y.
References
- 1.Hoshi T, Armstrong CM. C-type inactivation of voltage-gated K+ channels: pore constriction or dilation? J. Gen. Physiol. 2013;141:151–160. doi: 10.1085/jgp.201210888. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.DeCoursey TE, Chandy KG, Gupta S, Cahalan MD. Voltage-gated K+ channels in human T lymphocytes: a role in mitogenesis? Nature. 1984;307:465–468. doi: 10.1038/307465a0. [DOI] [PubMed] [Google Scholar]
- 3.Panyi G, Sheng Z, Deutsch C. C-type inactivation of a voltage-gated K+ channel occurs by a cooperative mechanism. Biophys. J. 1995;69:896–903. doi: 10.1016/S0006-3495(95)79963-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Cahalan MD, Chandy KG. The functional network of ion channels in T lymphocytes. Immunol. Rev. 2009;231:59–87. doi: 10.1111/j.1600-065X.2009.00816.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Wulff H, Christophersen P, Colussi P, Chandy KG, Yarov-Yarovoy V. Antibodies and venom peptides: new modalities for ion channels. Nat. Rev. Drug Discov. 2019;18:339–357. doi: 10.1038/s41573-019-0013-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Tarcha EJ, et al. Safety and pharmacodynamics of dalazatide, a KV1.3 channel inhibitor, in the treatment of plaque psoriasis: a randomized phase 1b trial. PLoS ONE. 2017;12:e0180762. doi: 10.1371/journal.pone.0180762. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Grissmer S, et al. Pharmacological characterization of five cloned voltage-gated K+ channels, types KV1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines. Mol. Pharmacol. 1994;45:1227–1234. [PubMed] [Google Scholar]
- 8.McCormack T, et al. The effects of Shaker beta-subunits on the human lymphocyte K+ channel KV1.3. J. Biol. Chem. 1999;274:20123–20126. doi: 10.1074/jbc.274.29.20123. [DOI] [PubMed] [Google Scholar]
- 9.Long SB, Campbell EB, Mackinnon R. Crystal structure of a mammalian voltage-dependent Shaker family K+ channel. Science. 2005;309:897–903. doi: 10.1126/science.1116269. [DOI] [PubMed] [Google Scholar]
- 10.Long SB, Tao X, Campbell EB, MacKinnon R. Atomic structure of a voltage-dependent K+ channel in a lipid membrane-like environment. Nature. 2007;450:376–382. doi: 10.1038/nature06265. [DOI] [PubMed] [Google Scholar]
- 11.Matthies D, et al. Single-particle cryo-EM structure of a voltage-activated potassium channel in lipid nanodiscs. eLife. 2018;7:e37558. doi: 10.7554/eLife.37558. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Long SB, Campbell EB, Mackinnon R. Voltage sensor of KV1.2: structural basis of electromechanical coupling. Science. 2005;309:903–908. doi: 10.1126/science.1116270. [DOI] [PubMed] [Google Scholar]
- 13.Tao X, Lee A, Limapichat W, Dougherty DA, MacKinnon R. A gating charge transfer center in voltage sensors. Science. 2010;328:67–73. doi: 10.1126/science.1185954. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Pless SA, Galpin JD, Niciforovic AP, Kurata HT, Ahern CA. Hydrogen bonds as molecular timers for slow inactivation in voltage-gated potassium channels. eLife. 2013;2:e01289. doi: 10.7554/eLife.01289. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Nguyen A, et al. Novel nonpeptide agents potently block the C-type inactivated conformation of KV1.3 and suppress T cell activation. Mol. Pharmacol. 1996;50:1672–1679. [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
Cryo-EM density maps and atomic coordinates of hKV1.3–KVβ2.1 and hKV1.3 H451N–KVβ2.1 have been deposited in the Electron Microscopy Data Bank under accession number EMD-31148 and 31149, and in the Protein Data Bank under accession code 7EJ1 and 7EJ2, respectively.